Status:
COMPLETED
Study to Investigate Safety, Tolerability and Pharmacokinetics of a Single Ascending Dose of AZD1704
Lead Sponsor:
AstraZeneca
Conditions:
Pain
Eligibility:
All Genders
20-45 years
Phase:
PHASE1
Brief Summary
The primary aim for this study is to investigate the safety and tolerability of the AZD1704, first time in man.
Eligibility Criteria
Inclusion
- Healthy volunteers, man or woman of non child-bearing potential
- Provision of signed informed consent.
Exclusion
- History of somatic disease/condition that may interfere with the objectives ot the study, as judged by the Investigator. History of seizures, with the exception of single occasions fever induced seizures in childhood.
- History of previous or ongoing psychiatric disease/condition including psychosis, affective disorder, anxiety disorder, borderline state and personality disorder according to the criteria in the DSM of Mental Disorder, 4th edition
- History of use of antipsychotic, antidepressant or anxiolytic drugs for the treatment of psychiatric disease or symptoms, prescribed as well as non-prescribed use.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00692042
Start Date
March 1 2008
End Date
June 1 2008
Last Update
June 24 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reserach Site
Macclesfield, Cheshire, United Kingdom